Industry experts share how their therapeutic products are shaping the future of the pharmaceutical landscape.

Is the regulator environment changing fast enough to accommodate the vast array of microbiome-based therapeutics beginning to emerge?

David Donabedian of Axial Biotherapuetics explains the role of the microbiome in the onset of Parkinson's Disease and autism.

How is the changing landscape of microbiome R&D shaping conversations with regulators?

Researchers at the University of Bath have developed a technique which could prevent drugs from spoiling.

Six members of the US's congress demand answers from the FDA as the risk of heparin shortages loom.

How can a mobile app help in medical adherence?

Maeve Magner explains how digital solutions can improve the supply chains of emerging economies.

A new vaccine could help give people at risk of HIV more options.

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.